Mein Warenkorb

Legumain

Legumain Produktliste

  • Attribut

    Protein (2)

  • Produktbibliothek

    Online (2)

  • Spezies

    Human (1)Mouse (1)

  • Etikett

    His Tag (2)

  • Marker

    Unconjugated (2)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
LEN-H52H3
Human
HEK293
Human Legumain Protein, His Tag (Pro-form)
In den Warenkorb legen
LEN-M52H3
Mouse
HEK293
Mouse Legumain Protein, His Tag (Pro-form, HPLC verified)
In den Warenkorb legen
Gesamtmenge2
  • 1

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Mouse nerve growth factor (Sinobioway Biomedicine)Phase 3 ClinicalSinobioway Biomedicine Co LtdDiabetic Foot; Optic Nerve Injuries
Details
Choroid plexus cell replacement therapy (Living Cell Technologies)Phase 3 ClinicalLiving Cell TechnologiesSurgical Wound Infection
Details
Recombinant human nerve growth factor (Sichuan ZehaTimes Pharmaceutical)Phase 2 ClinicalSichuan ZehaTimes Pharmaceutical Co LtdOptic Nerve Injuries
Details
Recombinant human nerve growth factor(Sinobioway Biomedicine)SMR001; SMR-001Phase 2 ClinicalSinobioway Biomedicine Co LtdXerophthalmia
Details
Recombinant human nerve growth factor (Xintrum Pharmacouticals)rh-NGFPhase 2 ClinicalJiangsu Zhongxin Pharmaceutical Co LtdKeratitis; Optic Nerve Injuries; Glaucoma, Open-Angle
Details
CHF-6467CHF-6467Phase 2 ClinicalChiesi Farmaceutici SPADiabetic Foot
Details
UdonitrectagREC-0559; MT-8; REC 0/0559Phase 2 ClinicalMimetech SRLKeratitis
Details
Recombinant human nerve growth factor(Chongqing Kerun Biologic)Phase 1 ClinicalKeratitis
Details
CD4^LVFOXP3 Treg-like cell therapyCD4^LVFOXP3Phase 1 ClinicalStanford UniversityPolyendocrinopathies, Autoimmune
Details
Beta-Nerve Growth Factor, Human (Aalborg University)Phase 1 ClinicalAalborg University Shakespeare CompanyPain; Hyperalgesia
Details
Recombinant human nerve growth factor (Beijing Tongren Hospital)Phase 1 ClinicalBeijing Tongren Hospital, CmuOptic Nerve Injuries
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
CenegerminrhNGF (Dompe Farmaceutici)ApprovedDompe Farmaceutici Spa欧适维, Sentinel, OxervateEUKeratitisDompé Pharmaceutici Spa2017-07-06Keratitis; Corneal Ulcer; Corneal Diseases; Dry Eye Syndromes; Retinitis Pigmentosa; Eye Diseases; Nervous System Diseases
Details
Mouse nerve growth factor (Wuhan Hiteck Bio-pharmaceutical)ApprovedWuhan Hiteck Biological Pharma Co Ltd金路捷Mainland ChinaTrauma, Nervous SystemWuhan Hiteck Biological Pharma Co Ltd2002-01-01Optic Nerve Injuries; Trauma, Nervous System
Details
Mouse nerve growth factor (Livzon Group)ApprovedLivzon Pharmaceutical Group Inc丽康乐Mainland ChinaOptic Nerve InjuriesLivzon(Group) Pharmaceutical Factory2010-05-07Optic Nerve Injuries
Details
Mouse nerve growth factor (Staidson Biopharma)Approved苏肽生Mainland ChinaOptic Nerve InjuriesStaidson(Beijing) Biopharmaceuticals Co Ltd2006-04-11Diabetic Foot; Optic Nerve Injuries; Peripheral Nerve Injuries
Details
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns